Understanding how specific cells in the retina process visual signals
Functional properties of amacrine cells in the mammalian retina
This study is looking at special cells in the eye called amacrine cells to understand how they help us see by processing visual information, which could lead to better treatments for vision problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11063173 on NIH RePORTER |
What this research studies
This research investigates the functional roles of amacrine cells in the mammalian retina, which are crucial for visual signal processing. Using advanced techniques like electrophysiological recordings, the study will analyze how these cells interact with other retinal cells to influence visual perception. The research will focus on genetically labeled amacrine cells and their synaptic mechanisms, aiming to uncover how they contribute to the processing of visual information under different light conditions. Patients may benefit from insights gained into retinal function and potential treatments for vision-related disorders.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with retinal disorders or those at risk of vision loss.
Not a fit: Patients with non-retinal related vision issues or those who do not have any retinal cell dysfunction may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating blindness and other visual impairments.
How similar studies have performed: Other research has shown success in understanding retinal cell functions, but this specific investigation into amacrine cells is relatively novel.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Taylor, William Rowland — University of California Berkeley
- Study coordinator: Taylor, William Rowland
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.